All articles
Site OperationsSeptember 7, 2026·3 min read

What High-Enrolling Sites Do Differently

What separates sites that consistently hit enrollment targets isn't a secret referral channel — it's a handful of unglamorous, repeatable habits around feasibility, ownership, funnel measurement, and follow-up.

By Trialflow Team

Sites that consistently hit or beat enrollment targets rarely have some secret referral channel. When you sit with them and go through their process, what stands out is how boring and repeatable everything is. Below are the patterns that show up again and again.

They decide fast on new studies

High enrollers treat feasibility as a triage decision, not a favor to the sponsor. They know roughly how many patients in their existing population fit the core criteria before responding, and they say no when the answer is thin. The result is a smaller portfolio with better per-study performance. Sites that take everything end up spreading coordinator attention so thin that nothing gets a real recruitment push.

A practical version of this: keep a one-page profile of your patient population — conditions, rough counts, common comorbidities, typical medication patterns, referral relationships. Update it quarterly. Most feasibility questions can be answered from it in twenty minutes.

Recruitment starts before the site initiation visit

The strongest sites build their outreach list during startup, not after activation. By the time the green light comes, they already have a pre-screened queue and a few appointments penciled in. Sites that wait until activation lose the first three or four weeks re-learning the protocol and pulling lists.

Concretely, during startup they:

  • Run the chart or registry query and clean the output
  • Draft and get IRB approval on outreach materials in parallel with the contract
  • Write the pre-screening script and have a coordinator role-play it
  • Identify the two or three referring clinicians who matter most for this indication

One person owns the number

Shared ownership of enrollment produces reliable underperformance. In high-enrolling sites, a specific person can tell you, without looking anything up, how many people were contacted last week, how many were screened, and what the current bottleneck is. That person isn't necessarily the PI or the site director — often it's a coordinator with the authority to change the approach.

Ownership also means the metric is visible. A whiteboard works. A weekly email works. What doesn't work is a report nobody reads.

They measure the funnel, not just the total

When enrollment stalls, a strong site can say where. Are we not reaching enough people? Reaching them but failing to book? Booking but they don't show? Showing but failing eligibility? Each of those has a different fix, and treating a screen-fail problem with more advertising wastes money.

If your eligibility failure rate is high on a specific criterion, that's a conversation with the sponsor about the criterion, or a change to your pre-screening questions — not a media buy.

Follow-up is relentless and polite

Across most site datasets, a meaningful share of enrollments come from second, third, and fourth contact attempts. High enrollers have a defined cadence — call, text, call, email, then a pause and one more attempt weeks later — and they log every touch. Low enrollers make one call, leave a voicemail, and mark the record closed.

They keep talking to people they couldn't enroll

A screen failure for one protocol is often a great candidate for the next. Sites with strong long-term numbers maintain a permission-based registry of people who expressed interest, with enough detail to re-query later. This is the closest thing to a durable competitive advantage a site can build.

Where to start

Pick one: assign single ownership of the enrollment number, or start recruitment work during startup instead of after activation. Both are free. Both usually change results within a cycle.

Enrolling studies shouldn't be this hard

Trialflow gives research sites one platform for lead management, AI trial matching, and recruitment analytics.

Request a Demo